The Star, MSN – CEO Jeffrey Okoro says introduction of the new HIV drug Lenacapavir, could protect vulnerable communities
November 4, 2025
Okoro says targeting high-risk, low-income communities in the initial rollout will ensure those who have historically faced barriers to treatment are not left behind.